search
Back to results

Internet Delivered ERITA for Nonsuicidal Self-Injury (ERITA)

Primary Purpose

Nonsuicidal Self-injury

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Emotion regulation individual therapy
Treatment as usual
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Nonsuicidal Self-injury focused on measuring NSSI

Eligibility Criteria

13 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ≥ 5 nonsuicidal self-injury episodes past year
  • ≥ 1 nonsuicidal self-injury episodes past month
  • having at least one parent who committed to participate in the parent program

Exclusion Criteria:

  • Severe suicidal ideation
  • a diagnosis of psychotic or bipolar I disorder or ongoing (past month) substance dependence
  • the presence of co-occurring psychological disorders that required immediate treatment (i.e., severe anorexia nervosa)
  • insufficient understanding of the Swedish language

Sites / Locations

  • Centre for Psychiatry Research Karolinska Institutet and Stockholm County Council
  • Karolinska Institutet

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Adjunctive Internet-delivered ERITA

Treatment as usual

Arm Description

Participants will receive 11 weeks of internet-delivered emotion regulation individual therapy with therapist support adjunctive to treatment as usual as provided in the community. The caregiver(s) will receive 6 modules of internet-delivered parent program with therapist support.

Participants will receive treatment as usual for 11 weeks of treatment as usual as provided in the community.

Outcomes

Primary Outcome Measures

Deliberate Self-Harm Inventory Youth version (DSHI-Y)
Frequency of nonsuicidal self-injury

Secondary Outcome Measures

Difficulties in Emotion Regulation Scale - 16 item version (DERS-16)
Difficulties in emotion regulation as primary potential mechanism of change. Ranges from 16-80, with higher scores indicating more difficulties.
Difficulties in Emotion Regulation Scale - 36 item version (DERS)
Difficulties in emotion regulation. Ranges from 36-180, with higher scores indicating more difficulties.
the 21-item Depression Anxiety Stress Scales (DASS-21)
Symptoms of depression, anxiety and stress. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating more symptoms.
Borderline Symptom List Supplement
Impulsive self-destructive behaviors
Acceptance and Action Questionnaire
Acceptance and valued actions. Ranges from 7-49, with higher scores indicating less acceptance and valued actions.
Childrens Global Assessment Scale
Global functioning. Ranges from 1-100, with higher scores indicating better functioning.
The Clinical Global Impressions -Severity and Improvement scales
Global symptom severity and improvement. Severity of illness scale ranges from 1-7, with higher scores indicating higher severity of illness. Global improvement scale ranges from 1-7 with lower scores indicating more improvement.

Full Information

First Posted
November 2, 2017
Last Updated
April 29, 2022
Sponsor
Karolinska Institutet
search

1. Study Identification

Unique Protocol Identification Number
NCT03353961
Brief Title
Internet Delivered ERITA for Nonsuicidal Self-Injury
Acronym
ERITA
Official Title
Internet Delivered Emotion Regulation Individual Therapy for Adolescents With Nonsuicidal Self-Injury: A Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
November 20, 2017 (Actual)
Primary Completion Date
January 7, 2021 (Actual)
Study Completion Date
October 17, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To evaluate if Internet delivered emotion regulation individual therapy for adolescents is an efficacious treatment when delivered as adjunctive to treatment as usual compared to a control group consisting of treatment as usual.
Detailed Description
Statistical Analyses Treatment effects will be evaluated according to the intention-to-treat principle. Primary end-point for all outcomes is post-treatment. Secondary end-point include a controlled 3 month follow-up. Primary Analysis The primary outcome analysis will include treatment group (ERITA , TAU) and weekly reports of NSSI frequency measured once every week 4 weeks prior to treatment start, once every week during treatment, and once every week four weeks after treatment termination. Regression analysis modelled for count data will be used to estimate trend over time. Four weeks after treatment termination will be considered primary endpoint. Pairwise contrasts (group x time interaction) from the regression model will be used to evaluate between-group differences at primary endpoint (4 weeks after treatment termination). Secondary Analyses Secondary outcomes measured once before, during, and after treatment will be analyzed in a similar fashion as for the primary outcome, modelled after data's distribution (count or continuous). Measures collected only once at baseline and post-treatment will be analyzed with regression analyses including treatment group (online ERITA , TAU) as the between-subjects factor, time (baseline to post) as the within-subjects factor, and group × time interactions, modelled after data's distribution (count or continuous). Parallel process latent growth curve modeling will be used to determine whether change in week-to-week emotion dysregulation (DERS-16) during treatment mediate the overall effect of ERITA+ETAU on week-to-week change in the primary outcome self-rated NSSI frequency (DSHI-Y). 3 Month Follow-Up Data collected at 3-month follow-up will be used to determine the extent to which potential treatment gains were maintained both within and between treatment conditions Update 28 April 2022: As a secondary analyses, we also aim to investigate the effect of treatment moderators (primary aim) and predictors (secondary aim) on NSSI frequency one month after treatment termination. This update was submitted prior to conducting the analyses. The selection of potential moderators was theoretically and empirically motivated. We will investigate the following variables (measured at baseline): Age Difficulties in emotion regulation As measured with the Difficulties in Emotion Regulation Scale - 36 item version (DERS) Past month NSSI frequency As measured with the Deliberate Self-Harm Inventory Youth version (DSHI-Y) Global functioning As measured with the Childrens Global Assessment Scale Depressive symptoms As measured with the 21-item Depression Anxiety Stress Scales (DASS-21) Sleep difficulties As measured with the Insomnia Severity Index (ISI) Parental Minimization - discounting or devaluing the child's negative emotions/problems As measured with The Coping with Children's Negative Emotions Scale Adolescent Version (CCNES-A), subscale minimazation Level of suicidality As measured with the MINI-KID International Neuropsychiatric Interview, version 6

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nonsuicidal Self-injury
Keywords
NSSI

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
166 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Adjunctive Internet-delivered ERITA
Arm Type
Experimental
Arm Description
Participants will receive 11 weeks of internet-delivered emotion regulation individual therapy with therapist support adjunctive to treatment as usual as provided in the community. The caregiver(s) will receive 6 modules of internet-delivered parent program with therapist support.
Arm Title
Treatment as usual
Arm Type
Active Comparator
Arm Description
Participants will receive treatment as usual for 11 weeks of treatment as usual as provided in the community.
Intervention Type
Behavioral
Intervention Name(s)
Emotion regulation individual therapy
Intervention Description
The emotion regulation individual therapy is delivered via an internet platform and includes therapist contact several times per week via the platform.
Intervention Type
Behavioral
Intervention Name(s)
Treatment as usual
Intervention Description
Treatment as usual as provided in the community.
Primary Outcome Measure Information:
Title
Deliberate Self-Harm Inventory Youth version (DSHI-Y)
Description
Frequency of nonsuicidal self-injury
Time Frame
Change from baseline, once every week during treatment (0-12 weeks after baseline), 3 and 12 months after treatment has ended
Secondary Outcome Measure Information:
Title
Difficulties in Emotion Regulation Scale - 16 item version (DERS-16)
Description
Difficulties in emotion regulation as primary potential mechanism of change. Ranges from 16-80, with higher scores indicating more difficulties.
Time Frame
Change from baseline, once every week during treatment (0-12 weeks after baseline), 3 and 12 months after treatment has ended
Title
Difficulties in Emotion Regulation Scale - 36 item version (DERS)
Description
Difficulties in emotion regulation. Ranges from 36-180, with higher scores indicating more difficulties.
Time Frame
Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended
Title
the 21-item Depression Anxiety Stress Scales (DASS-21)
Description
Symptoms of depression, anxiety and stress. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating more symptoms.
Time Frame
Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended
Title
Borderline Symptom List Supplement
Description
Impulsive self-destructive behaviors
Time Frame
Change from baseline, once every week during treatment (0-12 weeks after baseline), 3 and 12 months after treatment has ended
Title
Acceptance and Action Questionnaire
Description
Acceptance and valued actions. Ranges from 7-49, with higher scores indicating less acceptance and valued actions.
Time Frame
Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended
Title
Childrens Global Assessment Scale
Description
Global functioning. Ranges from 1-100, with higher scores indicating better functioning.
Time Frame
Change from baseline, 16 weeks after treatment starts, 3 months after treatment has ended
Title
The Clinical Global Impressions -Severity and Improvement scales
Description
Global symptom severity and improvement. Severity of illness scale ranges from 1-7, with higher scores indicating higher severity of illness. Global improvement scale ranges from 1-7 with lower scores indicating more improvement.
Time Frame
Change from baseline, 16 weeks after treatment starts, 3 months after treatment has ended
Other Pre-specified Outcome Measures:
Title
Short version of the Experiences in Close Relationships Scale - Revised Child version
Description
Experiences in close relationships. Ranges from 12-84, with higher scores indicating greater problems.
Time Frame
Change from baseline, once every second week during treatment (0-12 weeks after baseline)
Title
Generalised Anxiety Disorder 7-item scale
Description
Worry. Ranges 0-21, with higher scores indicating more worry.
Time Frame
Change from baseline, once every second week during treatment (0-12 weeks after baseline)
Title
Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version
Description
Costs associated with psychiatric illness
Time Frame
Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended
Title
Kidscreen-10
Description
Quality of life. Ranges 11-55, with higher scores indicating higher quality in life.
Time Frame
Change from baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended
Title
Patient Internet-delivered cognitive behavioral Adherence Scale
Description
Patient adherence to treatment. Ranges from 0-20, with higher scores indicating higher adherence.
Time Frame
6 and 12 weeks after baseline
Title
Working Alliance Inventory
Description
Working alliance with online therapist
Time Frame
4 weeks after treatment starts
Title
The Coping with Children's Negative Emotions Scale Adolescent Version
Description
Parents' perceived ability to cope with children's negative emotions. Three subscales will be used derived to reflect the specific types of coping response parents tend to use in these situations (punitive reactions, problem focused reactions, and minimization reactions). Each subscale ranges from 1-7.
Time Frame
Change from baseline, 6 and 12 weeks after treatment starts, 3 and 12 months after treatment has ended
Title
The Client Satisfaction Questionnaire
Description
Client satisfaction with treatment. Ranges from 8-32 with higher scores indicating greater treatment satisfaction.
Time Frame
12 weeks after treatment starts
Title
Adverse Events
Description
Self-rating scale that measures adverse events related to treatment
Time Frame
12 weeks after treatment starts
Title
Credibility/Expectancy Questionnaire
Description
Treatment credibility and expectancy. Ranges from 0-50 with higher scores indicating greater credibility/expectancy.
Time Frame
1 week after treatment starts

10. Eligibility

Sex
All
Minimum Age & Unit of Time
13 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥ 5 nonsuicidal self-injury episodes past year ≥ 1 nonsuicidal self-injury episodes past month having at least one parent who committed to participate in the parent program Exclusion Criteria: Severe suicidal ideation a diagnosis of psychotic or bipolar I disorder or ongoing (past month) substance dependence the presence of co-occurring psychological disorders that required immediate treatment (i.e., severe anorexia nervosa) insufficient understanding of the Swedish language
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clara Hellner, PhD, MD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre for Psychiatry Research Karolinska Institutet and Stockholm County Council
City
Stockholm
ZIP/Postal Code
113 64
Country
Sweden
Facility Name
Karolinska Institutet
City
Stockholm
ZIP/Postal Code
113 64
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33677832
Citation
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Interventions for self-harm in children and adolescents. Cochrane Database Syst Rev. 2021 Mar 7;3(3):CD013667. doi: 10.1002/14651858.CD013667.pub2.
Results Reference
derived

Learn more about this trial

Internet Delivered ERITA for Nonsuicidal Self-Injury

We'll reach out to this number within 24 hrs